We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Spray-On Influenza Virus Barrier

By HospiMedica staff writers
Posted on 14 Dec 2005
A compound sprayed on respiratory mask air filters reduces viruses passing through and also deactivates the live viruses that do manage to pass through the filters.

Quigley Pharma's QR-441 compound, manufactured by Quigley Pharma (Doylestown, PA, USA), has been tested against avian influenza virus H5N1 and human influenza virus H3N2. More...
When sprayed on respiratory mask air filters, the QR-441 impregnated masks prevented up to 99% of the viruses from passing through, whereas the masks not treated with QR-441 had the ability to prevent up to 90% of the viruses from passing through. More important, the findings show that the QR-441 compound proved to deactivate the live viruses passing through these filters. Deactivation of live viruses in a range of 95.1-98.7% was observed in the studies.

Quigley Pharma develops pharmaceutical compounds targeting diverse conditions by utilizing natural sources of medicinal substances and investigation into traditional medicine and historic therapeutics.

"If there is an outbreak of avian flu in our U.S. human population, initially it will be easier to distribute the formula as a spray to be used on the exterior of commercially available masks than to develop and distribute a new style mask using the compound.” said Charles A. Phillips, senior vice president of Quigley Pharma. "In an emergency situation, the spray formula's increased ability to stop the virus from penetrating these masks may help reduce viral transmission.”

The company is pursuing use of the vaccine by government healthcare and poultry workers for a possible avian influenza outbreak preparedness program, the slaughter and disposal of infected birds and cleanup operations, for emergency medical type masks and isolation face masks, and for U.S. Homeland Security applications.




Related Links:
Quigley Pharma

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology System
Riviera SPV AT
Silver Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.